Get started
Author

Anas Najjar

Institution: Al-Quds University
ORCID: 0000-0001-7295-2957
Observed ORCID: 0000-0001-7295-2957
OpenAlex ID: A5080733907
Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
2017 · Fatma Haddad, Maryam Sawalha, et al. · Molecules · 204
PDF
The prodrug approach in the era of drug design
2018 · Anas Najjar, Rafik Karaman · Expert Opinion on Drug Delivery · 98
PDF
Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review
2018 · Isra’ Zeiadeh, Anas Najjar, et al. · Molecules · 75
PDF
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
2020 · Anas Najjar, Abderrahman Najjar, et al. · Molecules · 72
PDF
Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem
2015 · Anas Najjar, Yazan Amro, et al. · PLoS ONE · 52
PDF
Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy
2017 · Anas Najjar, Naeema Rajabi, et al. · Current Pharmaceutical Design · 51
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
2017 · Hanadi Sinokrot, Tasneem Smerat, et al. · Molecules · 44
PDF
Successes, failures, and future prospects of prodrugs and their clinical impact
2019 · Anas Najjar, Rafik Karaman · Expert Opinion on Drug Discovery · 28
Prevalence of chronic diseases in older Palestinian adults and common pharmacological interventions: a cross-sectional study
2021 · Anas Najjar, Beesan Warasna, et al. · The Lancet · 6
PDF
Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study
2021 · Beesan Warasna, Naeema Rajabi, et al. · The Lancet · 2
PDF
Recent Advances in the Prodrug Approach to Parkinson's Disease Therapy
2024 · Donia Karaman, Fatma Haddad, et al. · Book Publisher International (a part of SCIENCEDOMAIN International)
Works count: 12
Citation count: 632
H-index: 8
I10-index: 8
Year
Topic
Type